Peter Scott (WIPR), Federico Rizzo (Diadora), Alessia Parassina (Brandstock)
In this webinar, we'll discuss the best approaches to IP portfolio management, hearing from industry on what they consider best practice and looking at potential solutions to help you manage your portfolio effectively.
As IP rights increase in importance to businesses, so do the threats to them, the costs of maintaining them, and the complexity of making good decisions about how to direct and manage them. This webinar will help you understand what strategies are available, and how to ensure that portfolio management is resource and cost-effective in your organisation.
Dr Claire Irvine (HGF Ltd), Sarah Morgan (Life Sciences IP Review)Recorded: Mar 12 201965 mins
CRISPR gene-editing continues to hit the headlines regularly as a ground-breaking technology with many millions now flowing into companies seeking to exploit the technology in both the therapeutic and agricultural fields. Unfortunately, the IP landscape continues to lack clarity with possibility of divergence between Europe and the US.
This webinar is aimed at those wishing to hear about the latest developments in the CRISPR IP landscape whether in the commercial, academic, legal or patent world. With the CRISPR IP saga seemingly not close to the final chapter, it will also provide an opportunity to raise questions which may arise from the on–going lack of clarity.
Douglas Drysdale, partner, HGFRecorded: Oct 11 201863 mins
The UK Supreme Court's 2017 decision in Actavis v Eli Lilly introduced a doctrine of equivalents into UK law. In this webinar, we'll discuss the implications of that decision and look at how it is being applied in other cases in the UK courts.
Dr. Laurence Gainey, Patent Director, HGFRecorded: Sep 11 201858 mins
Personalised healthcare (sometimes referred to as precision medicine) is an evolving field in medicine where a therapeutic treatment is tailored to an individual with a particular disease. The patenting of personalised healthcare inventions has proved problematic in a number of jurisdictions, most notably the USA. However, various aspects of these inventions are patentable in Europe.
This webinar will set the scene as to what personalised healthcare is and will run through the history of second medical use patenting in Europe. Discussing key cases such as G5/83, T1020/03 and G2/08.
It will then focus on how second medical use patenting can be applied to personalised healthcare inventions and will give examples of claim language that is finding favour at the EPO.
Catherine Coombes (HGF), Dr. Chris Moore (HGF), Peter Scott (WIPR)Recorded: Mar 21 201842 mins
This webinar will be on opposition and appeals practice before the EPO. We’ll be discussing the streamlining of the opposition procedure by the EPO, the changes that we are seeing as a result and will be providing practical tips in view of these changes. The talk will also draw on recent case law.
Gerald Murphy (BSKB), John Heithaus (BSKB), Peter Scott (WIPR)Recorded: Jan 30 201863 mins
Over the last 10 years, multiple patents on therapeutic antibodies have been invalidated in the courts, often for lack of written description. Many other cases are working their way through the courts and the PTAB. This webinar will review major CAFC and PTAB decisions affecting therapeutic antibodies and will explore the best ways to obtain valuable and enforceable patents on therapeutic antibodies. The main issues to be covered are Section 101 issues (laws of nature, natural phenomena and natural products), obviousness and written description.
Guido Chiavelli (CEO, Il Gufo), Alessia Parassina (Lawyer, Brandstock), Angela La Marca (IP counsel) Ed Conlon (WIPR),Recorded: Oct 26 201758 mins
With the year approaching its end, many IP departments will be looking at how best to rationalise their work for 2018. This webinar explores how to ensure your trademark portfolio is in the best possible shape using a two part verification and audit process to save you time and money on your IP assets, as well as analyzing your current and planned costs and guiding your filing strategy in the new year.
Caroline Chenique (Global Director of Sales & Marketing, RWS), Justin Simpson (RWS, founder of inovia) and Ed Conlon (WIPR)Recorded: Oct 17 201742 mins
Join WIPR and RWS IP Services for a complimentary webinar as we discuss patent filing strategies in China.
As the largest growing consumer market in the world, enforcing your intellectual property (IP) in China has become increasingly critical. In this webinar, we will discuss the ten steps your organization should take when seeking patent protection and help you formulate your commercial IP strategy.
Iain Armstrong (Partner, HGF), Dr. Laurence Gainey (Patent Director, HGF) and Peter Scott (Publisher, WIPR/LSIPR)Recorded: Sep 27 201758 mins
This webinar will cover the current state of play in Europe regarding biotech patentability issues, including recent case law on what data you need to make an invention in this area plausible. It will also look at how recent rule changes have influenced patentability of plants and animals before the EPO. Finally, we will compare patentability practice in different jurisdictions around the world, most notably in the US, China and Japan.